The reduction in fatty acid oxidation is at least partially mediated by the downregulation of PPAR-α and PGC1- α, which has been shown in a rodent HF models as well as in patients with both ischemic and non-ischemic end-stage HF (33, 34). Here, PPARGC1A is linked to hydrops fetalis.